Dimitri Ryczko
Réjean Dubuc- 1Groupe de Recherche sur le Système Nerveux Central, Département de Neurosciences, Université de Montréal, Montréal, QC, Canada
- 2Groupe de Recherche en Activité Physique Adaptée, Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, QC, Canada
In vertebrates, dopamine neurons are classically known to modulate locomotion via their ascending projections to the basal ganglia that project to brainstem locomotor networks. An increased dopaminergic tone is associated with increase in locomotor activity. In pathological conditions where dopamine cells are lost, such as in Parkinson's disease, locomotor deficits are traditionally associated with the reduced ascending dopaminergic input to the basal ganglia. However, a descending dopaminergic pathway originating from the substantia nigra pars compacta was recently discovered. It innervates the mesencephalic locomotor region (MLR) from basal vertebrates to mammals. This pathway was shown to increase locomotor output in lampreys, and could very well play an important role in mammals. Here, we provide a detailed account on the newly found dopaminergic pathway in lamprey, salamander, rat, monkey, and human. In lampreys and salamanders, dopamine release in the MLR is associated with the activation of reticulospinal neurons that carry the locomotor command to the spinal cord. Dopamine release in the MLR potentiates locomotor movements through a D1-receptor mechanism in lampreys. In rats, stimulation of the substantia nigra pars compacta elicited dopamine release in the pedunculopontine nucleus, a known part of the MLR. In a monkey model of Parkinson's disease, a reduced dopaminergic innervation of the brainstem locomotor networks was reported. Dopaminergic fibers are also present in human pedunculopontine nucleus. We discuss the conserved locomotor role of this pathway from lamprey to mammals, and the hypothesis that this pathway could play a role in the locomotor deficits reported in Parkinson's disease.
Ascending Dopaminergic Pathway and Locomotion
Dopaminergic neurons degenerate in patients with Parkinson's disease (PD), resulting in serious motor dysfunctions including locomotor deficits (falls, gait freezing, dysfunctional turning), which constitute major problems in advanced forms of the disease (Stack and Ashburn, 2008, for review see Bloem et al., 2004). These locomotor deficits are traditionally associated with a loss of the ascending dopaminergic projections from the substantia nigra pars compacta (SNc) to the basal ganglia (Carlsson et al., 1958; Carlsson, 1959; Sano et al., 1959; Poirier and Sourkes, 1965; Sourkes and Poirier, 1965; Albin et al., 1989; Ehringer and Hornykiewicz, 1998; Kravitz et al., 2010; Roseberry et al., 2016, for review see Fahn, 2015). In turn, the basal ganglia project down to the Mesencephalic Locomotor Region (MLR), a brainstem region that controls locomotion in vertebrates (Shik et al., 1966; for review see Ryczko and Dubuc, 2013, Figure 1). The MLR was initially found in cats to initiate locomotion and control its frequency and intensity (Shik et al., 1966). It was later identified in lamprey (Sirota et al., 2000), salamander (Cabelguen et al., 2003), stingray (Bernau et al., 1991), bird (Sholomenko et al., 1991), rat (Garcia-Rill et al., 1987), mouse (Lee et al., 2014; Roseberry et al., 2016), rabbit (Musienko et al., 2008), guinea-pig (Marlinsky and Voitenko, 1991), and monkey (Eidelberg et al., 1981; Karachi et al., 2010; Goetz et al., 2016a). In basal vertebrates, the MLR comprises the laterodorsal tegmental nucleus and the pedunculopontine nucleus (PPN). In mammals, it comprises the PPN, but also the cuneiform nucleus (CnF). In humans, damage to the MLR is associated with locomotor deficits (Masdeu et al., 1994; Kuo et al., 2008; Demain et al., 2014). The MLR is explored as a target for deep brain stimulation to improve locomotor function in Parkinsonian patients (Plaha and Gill, 2005; for review see Hamani et al., 2016a,b).
Figure 1. The descending dopaminergic pathway recently uncovered in vertebrates. Schematic representation of the connectivity between the meso-diencephalic dopamine cells, the basal ganglia, the Mesencephalic Locomotor Region (MLR), the reticulospinal cells (RS), and the Central Pattern Generator (CPG) for locomotion. The meso-diencephalic dopamine cells refer to the posterior tuberculum in basal vertebrates and to the substantia nigra pars compacta in mammals. For convenience, the well-established direct and indirect pathways within the basal ganglia are not illustrated. (Adapted from (Le Ray et al., 2011). No permission is required for this reproduction).
The ascending dopaminergic projections mostly target the striatum, a major entry of the basal ganglia. These projections favor locomotion initiation by increasing the excitability of D1-expressing striatal neurons of the direct pathway, and this reduces the tonic inhibition sent by the output stations of the basal ganglia to the MLR. In parallel, dopamine decreases the excitability of D2-expressing striatal neurons of the indirect pathway. This also contributes to disinhibit the MLR, and initiate movement (Albin et al., 1989; Kravitz et al., 2010; Freeze et al., 2013; Roseberry et al., 2016). Such organization is conserved within the basal ganglia from lamprey to mammals (see Grillner and Robertson, 2016). Once disinhibited, the MLR initiates locomotion by sending descending excitatory inputs to reticulospinal neurons, which activate the central pattern generator for locomotion (Figure 1, cat: Orlovskii, 1970; Steeves and Jordan, 1980; Garcia-Rill and Skinner, 1987a,b; Noga et al., 1988, 1991; rat: Bachmann et al., 2013; bird: Sholomenko et al., 1991; lamprey: Buchanan and Grillner, 1987; Brodin et al., 1988; Ohta and Grillner, 1989; Brocard and Dubuc, 2003; Le Ray et al., 2003; mouse: Bretzner and Brownstone, 2013; salamander: Ryczko et al., 2016b). MLR glutamatergic neurons are of primary importance to activate reticulospinal neurons and elicit locomotion (lamprey: Brocard and Dubuc, 2003, salamander: Ryczko et al., 2016b, mouse: Lee et al., 2014; Roseberry et al., 2016). MLR cholinergic neurons provide additional excitation to reticulospinal cells (lamprey: Le Ray et al., 2003; Smetana et al., 2010; mouse: Roseberry et al., 2016). The functional significance of this circuitry was elegantly summed in a mouse study, in which it was shown that ascending dopaminergic pathways to the basal ganglia indirectly control MLR glutamatergic cells and locomotion (Roseberry et al., 2016). The loss of the ascending dopaminergic pathway is thus considered the main cause of locomotor deficits in PD.
A New Descending Dopaminergic Pathway has been Unraveled
There was some indication in the literature that in addition to their ascending projections, dopaminergic cells also sent direct descending projections to brainstem locomotor networks. In rat, dopamine was detected using radiometric assays or microdialysis in the CnF (Versteeg et al., 1976; Saavedra et al., 1979) and PPN (Steiniger and Kretschmer, 2003) that are both part of the MLR in mammals (see Ryczko and Dubuc, 2013). Moreover, dopaminergic fibers were detected in rat brainstem using immunohistochemistry (Kitahama et al., 2000). In monkey, dopaminergic terminals were found in proximity with cholinergic cells of the PPN and CnF (Rolland et al., 2009). The origin of this dopaminergic projection remained unknown, but tracing studies mentioned a descending projection from the SNc to the PPN in rat (Beckstead et al., 1979; Semba and Fibiger, 1992; Steininger et al., 1992; Ichinohe et al., 2000) and in cat (Edley and Graybiel, 1983). The presence of such descending input was also supported by recordings of short latency antidromic activation of SNc neurons following PPN stimulation in rat (Scarnati et al., 1984, 1987).
We investigated the origin of the dopaminergic innervation of the MLR in vertebrates. In lamprey (Ryczko et al., 2013) and salamander (Ryczko et al., 2016a), dopaminergic fibers were found around MLR cholinergic cells, a conserved landmark of the MLR (see Ryczko and Dubuc, 2013). We identified the origin of this dopaminergic innervation in lamprey (Figure 2G, Ryczko et al., 2013; see also Perez-Fernandez et al., 2014) and in salamander (Figure 2H, Ryczko et al., 2016a) as a diencephalic dopaminergic region called the posterior tuberculum. This region sends ascending projection to the striatum, and is considered homologous to the mammalian SNc and/or ventral tegmental area (Marin et al., 1997; Pombal et al., 1997; Puelles and Verney, 1998; Smeets et al., 2000; Rink and Wullimann, 2001; Blin et al., 2008; for review see Yamamoto and Vernier, 2011; Wullimann, 2014). We then found that such “new pathway” (Figure 1) is conserved in higher vertebrates. In rat, PPN cholinergic cells were innervated by dopaminergic fibers (Ryczko et al., 2016a). Using virogenetic tracing, we found that the dopaminergic innervation of the rat MLR originates from the SNc and to a lesser extent the retrorubral field (Figure 2I, Ryczko et al., 2016a). This was confirmed using conventional tracers coupled with immunofluorescence experiments (Ryczko et al., 2016a). While only a few dopamine neurons sent both an ascending projection to the striatum and a descending one to the MLR in lampreys and salamanders, numerous SNc dopamine neurons sent both ascending and descending projections in rats. The proportion of the ascending dopaminergic projection may have increased during evolution due to the expansion of the basal ganglia (see Grillner and Robertson, 2016). We then found in the human brain that PPN cholinergic cells are surrounded by dopaminergic fibers (Figures 2J–L, Ryczko et al., 2016a), indicating that the innervation of the MLR is conserved in vertebrates.
Figure 2. The descending dopaminergic (DA) pathway is conserved from basal vertebrates to mammals. (A–F) Dopamine is released in the MLR after chemical stimulation of DA cells in the posterior tuberculum (PT) of lampreys (A,D) or salamanders (in vitro isolated brain) (B,E), or after electrical stimulation of the substantia nigra pars compacta (SNc) in rats (anesthetized) (C,F). (D–F) mean ± sem is illustrated. (G) Lamprey tyrosine hydroxylase (TH)-containing cells (red) in the PT and cells projecting to the MLR (green) with arrows indicating double labeled cells. (H) Salamander TH-containing cells (red) in the PT and cells projecting to the MLR (green) with arrows indicating double labeled cells. (I) DA cells in the SNc retrogradely labeled by an injection of a Cre-dependent adeno-associated virus encoding for the enhanced yellow fluorescent protein (EYFP, green) in the MLR of transgenic rats expressing the Cre-recombinase in TH neurons as shown by immunostaining against TH (red). (J–L) DA innervation of the human MLR. (J–L) The location of cholinergic cells (choline acetyltransferase-positive, ChAT) of the pedunculopontine nucleus (PPN), part of the MLR, is indicated. (L) Fibers containing the dopamine active transporter (DAT, red, highlighted by arrows) in proximity with cholinergic cells (ChAT, green) in the PPN. IC, inferior colliculus; SC, superior colliculus. (Panels A,D,G adapted from D. Ryczko, S. Gratsch, F. Auclair, C. Dube, S. Bergeron, M.H. Alpert, J.J. Cone, M.F. Roitman, S. Alford, and R. Dubuc, Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proceedings of the National Academy of Sciences of the United States of America 110 (2013) E3235–E3242. No permission is required for this reproduction; panels B,C,E,F,H,I,J–L adapted from D. Ryczko, J.J. Cone, M.H. Alpert, L. Goetz, F. Auclair, C. Dube, M. Parent, M.F. Roitman, S. Alford, and R. Dubuc, A descending dopamine pathway conserved from basal vertebrates to mammals. Proceedings of the National Academy of Sciences of the United States of America 113 (2016) E2440–E2449. No permission is required for this reproduction).
The descending dopaminergic pathway was shown to release dopamine in the MLR with fast-scan voltammetry (Ryczko et al., 2016a). Stimulation of the dopaminergic region evoked dopamine release in the MLR in vitro in lamprey (Figures 2A,D, Ryczko et al., 2013) and in salamander (Figures 2B,E, Ryczko et al., 2016a). In rat, SNc stimulation evoked dopamine release in the PPN in vivo (Figures 2C,F) that was potentiated by intraperitoneal amphetamine injection (Ryczko et al., 2016a). Altogether, these results established that the descending dopaminergic pathway is conserved and functional from basal vertebrates (lampreys, salamanders) to mammals (rats).
The role of the descending dopaminergic pathway in modulating locomotor activity was examined in two basal vertebrates. In lampreys and salamanders, stimulation of the dopamine region evoked dopamine release in the MLR, associated with activation of reticulospinal cells, which carry the locomotor command to the spinal cord (Ryczko et al., 2013, 2016a). There was a precise correlation in time linking MLR dopamine release and the activation of reticulospinal cells. The behavioral role of dopamine release in the MLR was examined in a lamprey semi-intact preparation (Ryczko et al., 2013), where the brain is exposed while the body swims as reported in many studies from our group (Sirota et al., 2000; Viana Di Prisco et al., 2000; Le Ray et al., 2003; Brocard et al., 2005, 2010; Gravel et al., 2007; Menard et al., 2007; Derjean et al., 2010; Smetana et al., 2010; Gariepy et al., 2012; Juvin et al., 2016). Stimulation of the dopaminergic region elicited reticulospinal activity together with locomotion, and microinjections of a D1 antagonist in the MLR decreased the number of locomotor cycles, the frequency of locomotor movements, and the duration of the locomotor bout (Ryczko et al., 2013). Conversely, microinjection of dopamine in the MLR had an opposite effect (Ryczko et al., 2013). In mammals, whether MLR dopamine release is associated with activation of the locomotor system remains to be addressed. The observation that amphetamine increases dopamine release in the rat MLR (Ryczko et al., 2016a) suggests an involvement of the descending dopaminergic pathway in the well-characterized increase in locomotor activity elicited by dopaminergic drugs (e.g., psychostimulants, L-DOPA).
The mechanisms through which dopamine potentiates MLR cell activity remain to be determined. It is possible that MLR dopamine enhances locomotor output by potentiating glutamatergic inputs to the MLR. In support of this, stimulation of the dopaminergic region evokes fast excitatory synaptic inputs in MLR cells in lampreys (Gariepy et al., 2012; Ryczko et al., 2013). This fast input could be glutamatergic and monosynaptic according to anatomical and electrophysiological data (Derjean et al., 2010). Future research should determine whether the two transmitters cooperate pre- and/or post-synaptically, and establish the role of dopaminergic inputs on intrinsic properties of MLR cells.
Possible Role of the Descending Dopaminergic Pathway in PD
There is accumulating evidence indicating that the MLR plays a similar role in humans as described in animal models. Moreover, it appears that some of the locomotor deficits observed in PD can be attributed to changes in the brainstem locomotor circuitry including the MLR. The PPN and CnF, both parts of the MLR, are activated in healthy individuals when they are asked to imagine that they are walking (Jahn et al., 2008; Snijders et al., 2011; Karachi et al., 2012; Peterson et al., 2014; Tattersall et al., 2014). In Parkinsonian subjects, similar observations were reported (Piallat et al., 2009; Lau et al., 2015; for review see Bohnen and Jahn, 2013). PPN activity increases during walking, and is modulated by L-DOPA with increase in alpha band (5–12 Hz) and decrease in beta (13–35) and gamma (65–90 Hz) bands (Fraix et al., 2013). Gait freezing is associated with a decreased alpha band activity in the PPN (Thevathasan et al., 2012). Motor arrests are associated with decreased blood oxygen levels in the MLR (Shine et al., 2013). Neuronal losses were reported in the PPN of patients with PD or progressive supranuclear palsy (Hirsch et al., 1987; Zweig et al., 1987, 1989; Jellinger, 1988). In PD this includes degeneration of cholinergic (Rinne et al., 2008; Karachi et al., 2010; Pienaar et al., 2013), GABAergic and glycinergic cells (Pienaar et al., 2013). Neuroimaging indicates that locomotor deficits in PD patients are associated with additional MLR abnormalities (notably in the PPN), including altered connectivity between the MLR, thalamus, and motor cortical regions (Fling et al., 2013, 2014), abnormal microstructure (Vercruysse et al., 2015; Youn et al., 2015; Wang et al., 2016), atrophy of the MLR gray matter (Snijders et al., 2011; Fioravanti et al., 2015) and abnormal metabolic activity following a walking task (Tard et al., 2015). Additionally, anatomopathological studies revealed the presence in the MLR of alpha-synuclein immuno-reactive Lewy Bodies (e.g., Seidel et al., 2015), and mitochondrial abnormalities (Pienaar et al., 2013) in PD. The severity of the locomotor deficits increases with the amplitude of PPN damage as captured by neuroimaging (Canu et al., 2015). These data are consistent with those showing that non-Parkinsonian individuals with MLR lesion display locomotor deficits (Masdeu et al., 1994; Kuo et al., 2008; Yeo et al., 2012), and that elderly with high level gait and balance disorders display midbrain gray matter atrophy including in the MLR (Demain et al., 2014). Finally, more and more studies point to the involvement of the PPN in the locomotor improvements related to deep brain stimulation of the subthalamic nucleus (human: Holiga et al., 2015; Knight et al., 2015; Weiss et al., 2015), which sends excitatory glutamatergic input to the PPN (e.g., Breit et al., 2001; Neagu et al., 2013; see Ryczko and Dubuc, 2013).
The benefits of MLR deep brain stimulation on locomotor function in PD (Plaha and Gill, 2005) are variable, from promising to modest (for recent studies, see Schrader et al., 2013; Mazzone et al., 2014; Holiga et al., 2015; Liu et al., 2015; Nosko et al., 2015; Welter et al., 2015) or unsustained benefits over the years (Mestre et al., 2016). This variability could be attributed to degeneration of MLR cells and to the variability of the brainstem anatomy from patient to patient (Mazzone et al., 2013). Reviewing the fast-growing body of literature on this neurosurgical approach is beyond the scope of the present review (for recent reviews, see Collomb-Clerc and Welter, 2015; DeLong and Wichmann, 2015; Fasano et al., 2015; Golestanirad et al., 2016; Rowe et al., 2016; Snijders et al., 2016). Several authors pointed out that adequate control trials and more standardization are needed before concluding on the efficacy of MLR deep brain stimulation (Windels et al., 2015; for review, see Hamani et al., 2016a,b).
The dopaminergic innervation of the PPN and CnF dramatically degenerates in a monkey model of PD (Rolland et al., 2009). The degeneration elicited by MPTP was even more marked in aged monkeys, maybe underlining the increasing fragility of this innervation over lifetime. The loss of dopaminergic innervation in the MLR could contribute to the pathophysiology of PD in several ways. If the role of the descending dopaminergic pathway to the MLR is conserved in higher vertebrates, locomotor deficits in PD may result, at least in part, from the loss of excitatory dopaminergic inputs to the MLR. This would lead to a reduced amplification of descending locomotor commands. Conversely, the descending dopaminergic pathway may improve locomotor function evoked by L-DOPA in people with PD (e.g., Moore et al., 2008; Chastan et al., 2009; Bryant et al., 2011a,b) by increasing the excitability of MLR cells. Importantly, locomotor deficits that are unresponsive to L-DOPA are associated with MLR degeneration (Chastan et al., 2009; Karachi et al., 2010; Snijders et al., 2011). It is thus possible that the beneficial effects of increasing dopamine release in the MLR with L-DOPA, or of stimulating MLR cells with dopaminergic agonists could improve locomotor function before MLR cells are lost in large number.
It is also possible that the loss of dopaminergic inputs to the MLR may disrupt the excitability of MLR cells, causing them to eventually degenerate. Such transneuronal degeneration can occur anterogradely or retrogradely and is characterized by a “structural deterioration of areas remote from the initial insult” (Fornito et al., 2015). This phenomenon was shown in the visual (e.g., Hubel and Wiesel, 1970; Herbin et al., 1999) and olfactory systems (e.g., Pinching and Powell, 1971). Transneuronal degeneration was also shown to damage dopaminergic neurons following striatal lesion (Macaya et al., 1994; Marti et al., 1997; El-Khodor and Burke, 2002; Canudas et al., 2005) and was proposed to contribute to PD (Pedersen and Schmidt, 2000). It was also proposed to occur in other neurodegenerative diseases including Alzheimer's disease and amyotrophic lateral sclerosis (see Fornito et al., 2015). The multiple alterations in the MLR in PD are compatible with such phenomenon (see Fornito et al., 2015). The reciprocal projections between the SNc and the PPN (McGeer and McGeer, 1984; Lavoie and Parent, 1994; Ryczko et al., 2013, 2016a; Perez-Fernandez et al., 2014) could also contribute to potentiate the transneuronal degeneration process. Nigral dopamine cell degeneration would cause a loss of the dopaminergic input to the MLR, causing MLR cells to degenerate. In turn, degeneration of PPN cholinergic and glutamatergic cells projecting to the nigral dopamine neurons would contribute to nigral dopamine cell loss. Studies in rat and monkey indicate that destruction of dopamine cells causes degeneration of MLR cholinergic cells (Pienaar et al., 2015b; Bensaid et al., 2016). Conversely, lesion of PPN cholinergic neurons induces a loss of dopaminergic nigral neurons (Bensaid et al., 2016). Finally, lesion of nigral dopaminergic neurons followed by lesion of PPN cholinergic cells induces a more dramatic degeneration of PPN cholinergic cells (Bensaid et al., 2016), suggesting that the two lesions interact to create a transneuronal degeneration loop. Stabilization of the reciprocal interactions between dopamine and cholinergic neurons could be a promising avenue to alleviate degeneration of the two systems. Interestingly, activation of PPN cholinergic cells with designer receptors exclusively activated by designer drugs (DREADDs) improves locomotor function in a rat model of PD (Pienaar et al., 2015a). It would be interesting to determine whether this approach would decrease degeneration of cholinergic and dopaminergic cells.
The descending dopaminergic projections to the PPN could also regulate other important functions such as cognition, sleep (Stefani et al., 2013; Karachi and Francois, 2017), modulation of visual inputs during locomotion (Lee et al., 2014), arousal state (Garcia-Rill et al., 2015a,b; Goetz et al., 2016b), motivation, and reward (Xiao et al., 2016; Yoo et al., 2017). How the descending dopaminergic input to the PPN influences these functions should be the subject of future research. Interestingly, the multifunctional aspects of the MLR, well established in lampreys (i.e., regulation of locomotion, respiration, control of sensory inputs, see Ryczko and Dubuc, 2013), are mirrored by the multifunctionality of the PPN in mammals.
In conclusion, studies carried out in two basal vertebrates (lampreys and salamanders) allowed us to discover a direct dopaminergic projection from the SNc down to the MLR. Several lines of evidence indicate that this new dopaminergic pathway is functional in rats, and could also be present in humans. Future research should address whether the descending dopaminergic pathway potentiates locomotion in mammals as in basal vertebrates, whether it contributes to other PPN functions, and whether this dopaminergic innervation degenerates in PD patients.
Author Contributors
DR and RD wrote the article.
Funding
This work was supported by the Canadian Institutes of Health Research Grant 15129 (to RD); the Natural Sciences and Engineering Research Council of Canada Grant 217435 (to RD); the Great Lakes Fishery Commission Grants 54011, 54021 and 54035 (to RD); the Parkinson Society Canada Grant 2011-11 (to RD); the Fonds de Recherche du Québec—Santé (FRQS: Groupe de Recherche sur le Système Nerveux Central, GRSNC, 5249). DR received fellowships from FRQS and the GRSNC Jasper fellowship.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We thank Danielle Veilleux for her technical assistance and Frédéric Bernard for his help with the graphics.
References
Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366–375. doi: 10.1016/0166-2236(89)90074-X
Bachmann, L. C., Matis, A., Lindau, N. T., Felder, P., Gullo, M., and Schwab, M. E. (2013). Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci. Transl. Med. 5:208ra146. doi: 10.1126/scitranslmed.3005972
Beckstead, R. M., Domesick, V. B., and Nauta, W. J. (1979). Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191–217. doi: 10.1016/0006-8993(79)91001-1
Bensaid, M., Michel, P. P., Clark, S. D., Hirsch, E. C., and Francois, C. (2016). Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease. Exp. Neurol. 275(Pt 1), 209–219. doi: 10.1016/j.expneurol.2015.11.004
Bernau, N. A., Puzdrowski, R. L., and Leonard, R. B. (1991). Identification of the midbrain locomotor region and its relation to descending locomotor pathways in the Atlantic stingray, Dasyatis sabina. Brain Res. 557, 83–94. doi: 10.1016/0006-8993(91)90119-G
Blin, M., Norton, W., Bally-Cuif, L., and Vernier, P. (2008). NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain. Mol. Cell. Neurosci. 39, 592–604. doi: 10.1016/j.mcn.2008.08.006
Bloem, B. R., Hausdorff, J. M., Visser, J. E., and Giladi, N. (2004). Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov. Disord. 19, 871–884. doi: 10.1002/mds.20115
Bohnen, N. I., and Jahn, K. (2013). Imaging: what can it tell us about parkinsonian gait? Mov. Disord. 28, 1492–1500. doi: 10.1002/mds.25534
Breit, S., Bouali-Benazzouz, R., Benabid, A. L., and Benazzouz, A. (2001). Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur. J. Neurosci. 14, 1833–1842. doi: 10.1046/j.0953-816x.2001.01800.x
Bretzner, F., and Brownstone, R. M. (2013). Lhx3-Chx10 reticulospinal neurons in locomotor circuits. J. Neurosci. 33, 14681–14692. doi: 10.1523/JNEUROSCI.5231-12.2013
Brocard, F., Bardy, C., and Dubuc, R. (2005). Modulatory effect of substance P to the brain stem locomotor command in lampreys. J. Neurophysiol. 93, 2127–2141. doi: 10.1152/jn.00401.2004
Brocard, F., and Dubuc, R. (2003). Differential contribution of reticulospinal cells to the control of locomotion induced by the mesencephalic locomotor region. J. Neurophysiol. 90, 1714–1727. doi: 10.1152/jn.00202.2003
Brocard, F., Ryczko, D., Fenelon, K., Hatem, R., Gonzales, D., Auclair, F., et al. (2010). The transformation of a unilateral locomotor command into a symmetrical bilateral activation in the brainstem. J. Neurosci. 30, 523–533. doi: 10.1523/JNEUROSCI.3433-09.2010
Brodin, L., Tossman, U., Ohta, Y., Ungerstedt, U., and Grillner, S. (1988). The effect of an uptake inhibitor (dihydrokainate) on endogenous excitatory amino acids in the lamprey spinal cord as revealed by microdialysis. Brain Res. 458, 166–169. doi: 10.1016/0006-8993(88)90511-2
Bryant, M. S., Rintala, D. H., Hou, J. G., Charness, A. L., Fernandez, A. L., Collins, R. L., et al. (2011a). Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment. Neurol. Res. 33, 959–964. doi: 10.1179/1743132811Y.0000000044
Bryant, M. S., Rintala, D. H., Hou, J. G., Lai, E. C., and Protas, E. J. (2011b). Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease. NeuroRehabilitation 29, 247–252. doi: 10.3233/NRE-2011-0700
Buchanan, J. T., and Grillner, S. (1987). Newly identified “glutamate interneurons” and their role in locomotion in the lamprey spinal cord. Science 236, 312–314. doi: 10.1126/science.3563512
Cabelguen, J. M., Bourcier-Lucas, C., and Dubuc, R. (2003). Bimodal locomotion elicited by electrical stimulation of the midbrain in the salamander Notophthalmus viridescens. J. Neurosci. 23, 2434–2439.
Canu, E., Agosta, F., Sarasso, E., Volonte, M. A., Basaia, S., Stojkovic, T., et al. (2015). Brain structural and functional connectivity in Parkinson's disease with freezing of gait. Hum. Brain Mapp. 36, 5064–5078. doi: 10.1002/hbm.22994
Canudas, A. M., Pezzi, S., Canals, J. M., Pallas, M., and Alberch, J. (2005). Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury. Brain Res. Mol. Brain Res. 134, 147–154. doi: 10.1016/j.molbrainres.2004.11.012
Carlsson, A. (1959). The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11, 490–493.
Carlsson, A., Lindqvist, M., Magnusson, T., and Waldeck, B. (1958). On the presence of 3-hydroxytyramine in brain. Science 127:471. doi: 10.1126/science.127.3296.471
Chastan, N., Do, M. C., Bonneville, F., Torny, F., Bloch, F., Westby, G. W., et al. (2009). Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity. Mov. Disord. 24, 188–195. doi: 10.1002/mds.22269
Collomb-Clerc, A., and Welter, M. L. (2015). Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: a systematic neurophysiological review. Neurophysiol. Clin. 45, 371–388. doi: 10.1016/j.neucli.2015.07.001
DeLong, M. R., and Wichmann, T. (2015). Basal ganglia circuits as targets for neuromodulation in Parkinson disease. JAMA Neurol. 72, 1354–1360. doi: 10.1001/jamaneurol.2015.2397
Demain, A., Westby, G. W., Fernandez-Vidal, S., Karachi, C., Bonneville, F., Do, M. C., et al. (2014). High-level gait and balance disorders in the elderly: a midbrain disease? J. Neurol. 261, 196–206. doi: 10.1007/s00415-013-7174-x
Derjean, D., Moussaddy, A., Atallah, E., St-Pierre, M., Auclair, F., Chang, S., et al. (2010). A novel neural substrate for the transformation of olfactory inputs into motor output. PLoS Biol. 8:e1000567. doi: 10.1371/journal.pbio.1000567
Di Prisco, G. V., Pearlstein, E., Le Ray, D., Robitaille, R., and Dubuc, R. (2000). A cellular mechanism for the transformation of a sensory input into a motor command. J. Neurosci. 20, 8169–8176.
Edley, S. M., and Graybiel, A. M. (1983). The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J. Comp. Neurol. 217, 187–215. doi: 10.1002/cne.902170207
Ehringer, H., and Hornykiewicz, O. (1998). Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism Relat. Disord. 4, 53–57. doi: 10.1016/S1353-8020(98)00012-1
Eidelberg, E., Walden, J. G., and Nguyen, L. H. (1981). Locomotor control in macaque monkeys. Brain 104, 647–663. doi: 10.1093/brain/104.4.647-a
El-Khodor, B. F., and Burke, R. E. (2002). Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J. Comp. Neurol. 452, 65–79. doi: 10.1002/cne.10367
Fahn, S. (2015). The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Mov. Disord. 30, 4–18. doi: 10.1002/mds.26102
Fasano, A., Aquino, C. C., Krauss, J. K., Honey, C. R., and Bloem, B. R. (2015). Axial disability and deep brain stimulation in patients with Parkinson disease. Nat. Rev. Neurol. 11, 98–110. doi: 10.1038/nrneurol.2014.252
Fioravanti, V., Benuzzi, F., Codeluppi, L., Contardi, S., Cavallieri, F., Nichelli, P., et al. (2015). MRI correlates of Parkinson's disease progression: a voxel based morphometry study. Parkinson's Dis. 2015:378032. doi: 10.1155/2015/378032
Fling, B. W., Cohen, R. G., Mancini, M., Carpenter, S. D., Fair, D. A., Nutt, J. G., et al. (2014). Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS ONE 9:e100291. doi: 10.1371/journal.pone.0100291
Fling, B. W., Cohen, R. G., Mancini, M., Nutt, J. G., Fair, D. A., and Horak, F. B. (2013). Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 136, 2405–2418. doi: 10.1093/brain/awt172
Fornito, A., Zalesky, A., and Breakspear, M. (2015). The connectomics of brain disorders. Nat. Rev. Neurosci. 16, 159–172. doi: 10.1038/nrn3901
Fraix, V., Bastin, J., David, O., Goetz, L., Ferraye, M., Benabid, A. L., et al. (2013). Pedunculopontine nucleus area oscillations during stance, stepping and freezing in Parkinson's disease. PLoS ONE 8:e83919. doi: 10.1371/journal.pone.0083919
Freeze, B. S., Kravitz, A. V., Hammack, N., Berke, J. D., and Kreitzer, A. C. (2013). Control of basal ganglia output by direct and indirect pathway projection neurons. J. Neurosci. 33, 18531–18539. doi: 10.1523/JNEUROSCI.1278-13.2013
Garcia-Rill, E., Houser, C. R., Skinner, R. D., Smith, W., and Woodward, D. J. (1987). Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus. Brain Res. Bull. 18, 731–738. doi: 10.1016/0361-9230(87)90208-5
Garcia-Rill, E., Luster, B., D'Onofrio, S., and Mahaffey, S. (2015a). Arousal, motor control, and parkinson's disease. Transl. Neurosci. 6, 198–207. doi: 10.1515/tnsci-2015-0021
Garcia-Rill, E., Luster, B., D'Onofrio, S., Mahaffey, S., Bisagno, V., and Urbano, F. J. (2015b). Pedunculopontine arousal system physiology - Deep brain stimulation (DBS). Sleep Sci. 8, 153–161. doi: 10.1016/j.slsci.2015.09.001
Garcia-Rill, E., and Skinner, R. D. (1987a). The mesencephalic locomotor region. I. Activation of a medullary projection site. Brain Res. 411, 1–12. doi: 10.1016/0006-8993(87)90675-5
Garcia-Rill, E., and Skinner, R. D. (1987b). The mesencephalic locomotor region. II. Projections to reticulospinal neurons. Brain Res. 411, 13–20. doi: 10.1016/0006-8993(87)90676-7
Gariepy, J. F., Missaghi, K., Chevallier, S., Chartre, S., Robert, M., Auclair, F., et al. (2012). Specific neural substrate linking respiration to locomotion. Proc. Natl. Acad. Sci. U.S.A. 109, E84–E92. doi: 10.1073/pnas.1113002109
Goetz, L., Piallat, B., Bhattacharjee, M., Mathieu, H., David, O., and Chabardes, S. (2016a). On the role of the pedunculopontine nucleus and mesencephalic reticular formation in locomotion in nonhuman primates. J. Neurosci. 36, 4917–4929. doi: 10.1523/JNEUROSCI.2514-15.2016
Goetz, L., Piallat, B., Bhattacharjee, M., Mathieu, H., David, O., and Chabardes, S. (2016b). The primate pedunculopontine nucleus region: towards a dual role in locomotion and waking state. J. Neural Transm. 123, 667–678. doi: 10.1007/s00702-016-1577-7
Golestanirad, L., Elahi, B., Graham, S. J., Das, S., and Wald, L. L. (2016). Efficacy and safety of pedunculopontine nuclei (PPN) deep brain stimulation in the treatment of gait disorders: a meta-analysis of clinical studies. Can. J. Neurol. Sci. 43, 120–126. doi: 10.1017/cjn.2015.318
Gravel, J., Brocard, F., Gariepy, J. F., Lund, J. P., and Dubuc, R. (2007). Modulation of respiratory activity by locomotion in lampreys. Neuroscience 144, 1120–1132. doi: 10.1016/j.neuroscience.2006.10.019
Grillner, S., and Robertson, B. (2016). The basal ganglia over 500 million years. Curr. Biol. 26, R1088–R1100. doi: 10.1016/j.cub.2016.06.041
Hamani, C., Aziz, T., Bloem, B. R., Brown, P., Chabardes, S., Coyne, T., et al. (2016a). Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical anatomy and terminology. Stereotact. Funct. Neurosurg. 94, 298–306. doi: 10.1159/000449010
Hamani, C., Lozano, A. M., Mazzone, P. A., Moro, E., Hutchison, W., Silburn, P. A., et al. (2016b). Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical techniques, side effects, and postoperative imaging. Stereotact. Funct. Neurosurg. 94, 307–319. doi: 10.1159/000449011
Herbin, M., Boire, D., Theoret, H., and Ptito, M. (1999). Transneuronal degeneration of retinal ganglion cells in early hemispherectomized monkeys. Neuroreport 10, 1447–1452. doi: 10.1097/00001756-199905140-00011
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., and Javoy-Agid, F. (1987). Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc. Natl. Acad. Sci. U.S.A. 84, 5976–5980. doi: 10.1073/pnas.84.16.5976
Holiga, S., Mueller, K., Moller, H. E., Urgosik, D., Ruzicka, E., Schroeter, M. L., et al. (2015). Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: indications of a principal role of the brainstem. NeuroImage Clin. 9, 264–274. doi: 10.1016/j.nicl.2015.08.008
Hubel, D. H., and Wiesel, T. N. (1970). The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J. Physiol. 206, 419–436. doi: 10.1113/jphysiol.1970.sp009022
Ichinohe, N., Teng, B., and Kitai, S. T. (2000). Morphological study of the tegmental pedunculopontine nucleus, substantia nigra and subthalamic nucleus, and their interconnections in rat organotypic culture. Anat. Embryol. 201, 435–453. doi: 10.1007/s004290050331
Jahn, K., Deutschlander, A., Stephan, T., Kalla, R., Wiesmann, M., Strupp, M., et al. (2008). Imaging human supraspinal locomotor centers in brainstem and cerebellum. Neuroimage 39, 786–792. doi: 10.1016/j.neuroimage.2007.09.047
Jellinger, K. (1988). The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 51, 540–543. doi: 10.1136/jnnp.51.4.540
Juvin, L., Gratsch, S., Trillaud-Doppia, E., Gariepy, J. F., Buschges, A., and Dubuc, R. (2016). A specific population of reticulospinal neurons controls the termination of locomotion. Cell Rep. 15, 2377–2386. doi: 10.1016/j.celrep.2016.05.029
Karachi, C., Andre, A., Bertasi, E., Bardinet, E., Lehericy, S., and Bernard, F. A. (2012). Functional parcellation of the lateral mesencephalus. J. Neurosci. 32, 9396–9401. doi: 10.1523/JNEUROSCI.0509-12.2012
Karachi, C., and Francois, C. (2017). Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys. J. Neural Transm. doi: 10.1007/s00702-017-1678-y. [Epub ahead of print].
Karachi, C., Grabli, D., Bernard, F. A., Tande, D., Wattiez, N., Belaid, H., et al. (2010). Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J. Clin. Invest. 120, 2745–2754. doi: 10.1172/JCI42642
Kitahama, K., Nagatsu, I., Geffard, M., and Maeda, T. (2000). Distribution of dopamine-immunoreactive fibers in the rat brainstem. J. Chem. Neuroanat. 18, 1–9. doi: 10.1016/S0891-0618(99)00047-2
Knight, E. J., Testini, P., Min, H. K., Gibson, W. S., Gorny, K. R., Favazza, C. P., et al. (2015). Motor and nonmotor circuitry activation induced by subthalamic nucleus deep brain stimulation in patients with parkinson disease: intraoperative functional magnetic resonance imaging for deep brain stimulation. Mayo Clin. Proc. 90, 773–785. doi: 10.1016/j.mayocp.2015.03.022
Kravitz, A. V., Freeze, B. S., Parker, P. R., Kay, K., Thwin, M. T., Deisseroth, K., et al. (2010). Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622–626. doi: 10.1038/nature09159
Kuo, S. H., Kenney, C., and Jankovic, J. (2008). Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov. Disord. 23, 616–619. doi: 10.1002/mds.21917
Lau, B., Welter, M. L., Belaid, H., Fernandez Vidal, S., Bardinet, E., Grabli, D., et al. (2015). The integrative role of the pedunculopontine nucleus in human gait. Brain 138, 1284–1296. doi: 10.1093/brain/awv047
Lavoie, B., and Parent, A. (1994). Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J. Comp. Neurol. 344, 232–241. doi: 10.1002/cne.903440205
Lee, A. M., Hoy, J. L., Bonci, A., Wilbrecht, L., Stryker, M. P., and Niell, C. M. (2014). Identification of a brainstem circuit regulating visual cortical state in parallel with locomotion. Neuron 83, 455–466. doi: 10.1016/j.neuron.2014.06.031
Le Ray, D., Brocard, F., Bourcier-Lucas, C., Auclair, F., Lafaille, P., and Dubuc, R. (2003). Nicotinic activation of reticulospinal cells involved in the control of swimming in lampreys. Eur. J. Neurosci. 17, 137–148. doi: 10.1046/j.1460-9568.2003.02417.x
Le Ray, D., Juvin, L., Ryczko, D., and Dubuc, R. (2011). Chapter 4–supraspinal control of locomotion: the mesencephalic locomotor region. Prog. Brain Res. 188, 51–70. doi: 10.1016/B978-0-444-53825-3.00009-7
Liu, H. G., Zhang, K., Yang, A. C., and Zhang, J. G. (2015). Deep brain stimulation of the subthalamic and pedunculopontine nucleus in a patient with Parkinson's disease. J. Korean Neurosurg. Soc. 57, 303–306. doi: 10.3340/jkns.2015.57.4.303
Macaya, A., Munell, F., Gubits, R. M., and Burke, R. E. (1994). Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. U.S.A. 91, 8117–8121. doi: 10.1073/pnas.91.17.8117
Marin, O., Smeets, W. J., and Gonzalez, A. (1997). Basal ganglia organization in amphibians: catecholaminergic innervation of the striatum and the nucleus accumbens. J. Comp. Neurol. 378, 50–69.
Marlinsky, V. V., and Voitenko, L. P. (1991). The effect of procaine injection into the medullary reticular formation on forelimb muscle activity evoked by mesencephalic locomotor region and vestibular stimulation in the decerebrated guinea-pig. Neuroscience 45, 753–759. doi: 10.1016/0306-4522(91)90287-X
Marti, M. J., James, C. J., Oo, T. F., Kelly, W. J., and Burke, R. E. (1997). Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17, 2030–2039.
Masdeu, J. C., Alampur, U., Cavaliere, R., and Tavoulareas, G. (1994). Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann. Neurol. 35, 619–621. doi: 10.1002/ana.410350517
Mazzone, P., Paoloni, M., Mangone, M., Santilli, V., Insola, A., Fini, M., et al. (2014). Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance. Gait Posture 40, 357–362. doi: 10.1016/j.gaitpost.2014.05.002
Mazzone, P., Sposato, S., Insola, A., and Scarnati, E. (2013). The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery 73, 894–906; discussion 905–906. doi: 10.1227/neu.0000000000000108
McGeer, E. G., and McGeer, P. L. (1984). Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum. Brain Res. 298, 339–342. doi: 10.1016/0006-8993(84)91433-1
Menard, A., Auclair, F., Bourcier-Lucas, C., Grillner, S., and Dubuc, R. (2007). Descending GABAergic projections to the mesencephalic locomotor region in the lamprey Petromyzon marinus. J. Comp. Neurol. 501, 260–273. doi: 10.1002/cne.21258
Mestre, T. A., Sidiropoulos, C., Hamani, C., Poon, Y. Y., Lozano, A. M., Lang, A. E., et al. (2016). Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease. Mov. Disord. 31, 1570–1574. doi: 10.1002/mds.26710
Moore, S. T., MacDougall, H. G., Gracies, J. M., and Ondo, W. G. (2008). Locomotor response to levodopa in fluctuating Parkinson's disease. Exp. Brain Res. 184, 469–478. doi: 10.1007/s00221-007-1113-y
Musienko, P. E., Zelenin, P. V., Lyalka, V. F., Orlovsky, G. N., and Deliagina, T. G. (2008). Postural performance in decerebrated rabbit. Behav. Brain Res. 190, 124–134. doi: 10.1016/j.bbr.2008.02.011
Neagu, B., Tsang, E., Mazzella, F., Hamani, C., Moro, E., Hodaie, M., et al. (2013). Pedunculopontine nucleus evoked potentials from subthalamic nucleus stimulation in Parkinson's disease. Exp. Neurol. 250, 221–227. doi: 10.1016/j.expneurol.2013.09.018
Noga, B. R., Kettler, J., and Jordan, L. M. (1988). Locomotion produced in mesencephalic cats by injections of putative transmitter substances and antagonists into the medial reticular formation and the pontomedullary locomotor strip. J. Neurosci. 8, 2074–2086.
Noga, B. R., Kriellaars, D. J., and Jordan, L. M. (1991). The effect of selective brainstem or spinal cord lesions on treadmill locomotion evoked by stimulation of the mesencephalic or pontomedullary locomotor regions. J. Neurosci. 11, 1691–1700.
Nosko, D., Ferraye, M. U., Fraix, V., Goetz, L., Chabardes, S., Pollak, P., et al. (2015). Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial. J. Neurol. Neurosurg. Psychiatry 86, 674–679. doi: 10.1136/jnnp-2013-307511
Ohta, Y., and Grillner, S. (1989). Monosynaptic excitatory amino acid transmission from the posterior rhombencephalic reticular nucleus to spinal neurons involved in the control of locomotion in lamprey. J. Neurophysiol. 62, 1079–1089.
Orlovskii, G. N. (1970). [Work of reticulo-spinal neurons during locomotion]. Biofizika 15, 728–737.
Pedersen, V., and Schmidt, W. J. (2000). The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs. Neurotox. Res. 2, 179–204. doi: 10.1007/BF03033793
Perez-Fernandez, J., Stephenson-Jones, M., Suryanarayana, S. M., Robertson, B., and Grillner, S. (2014). Evolutionarily conserved organization of the dopaminergic system in lamprey: SNc/VTA afferent and efferent connectivity and D2 receptor expression. J. Comp. Neurol. 522, 3775–3794. doi: 10.1002/cne.23639
Peterson, D. S., Pickett, K. A., Duncan, R., Perlmutter, J., and Earhart, G. M. (2014). Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS ONE 9:e90634. doi: 10.1371/journal.pone.0090634
Piallat, B., Chabardes, S., Torres, N., Fraix, V., Goetz, L., Seigneuret, E., et al. (2009). Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience 158, 1201–1205. doi: 10.1016/j.neuroscience.2008.10.046
Pienaar, I. S., Elson, J. L., Racca, C., Nelson, G., Turnbull, D. M., and Morris, C. M. (2013). Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am. J. Pathol. 183, 1826–1840. doi: 10.1016/j.ajpath.2013.09.002
Pienaar, I. S., Gartside, S. E., Sharma, P., De Paola, V., Gretenkord, S., Withers, D., et al. (2015a). Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Mol. Neurodegener. 10:47. doi: 10.1186/s13024-015-0044-5
Pienaar, I. S., Harrison, I. F., Elson, J. L., Bury, A., Woll, P., Simon, A. K., et al. (2015b). An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. Brain Struct. Funct. 220, 479–500. doi: 10.1007/s00429-013-0669-5
Pinching, A. J., and Powell, T. P. (1971). Ultrastructural features of transneuronal cell degeneration in the olfactory system. J. Cell Sci. 8, 253–287.
Plaha, P., and Gill, S. S. (2005). Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16, 1883–1887. doi: 10.1097/01.wnr.0000187637.20771.a0
Poirier, L., and Sourkes, T. L. (1965). Influence of the substantia nigra on the catecholamine content of the striatum. Brain 88, 181–192. doi: 10.1093/brain/88.1.181
Pombal, M. A., El Manira, A., and Grillner, S. (1997). Afferents of the lamprey striatum with special reference to the dopaminergic system: a combined tracing and immunohistochemical study. J. Comp. Neurol. 386, 71–91.
Puelles, L., and Verney, C. (1998). Early neuromeric distribution of tyrosine-hydroxylase-immunoreactive neurons in human embryos. J. Comp. Neurol. 394, 283–308.
Rink, E., and Wullimann, M. F. (2001). The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 889, 316–330. doi: 10.1016/S0006-8993(00)03174-7
Rinne, J. O., Ma, S. Y., Lee, M. S., Collan, Y., and Roytta, M. (2008). Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat. Disord. 14, 553–557. doi: 10.1016/j.parkreldis.2008.01.006
Rolland, A. S., Tande, D., Herrero, M. T., Luquin, M. R., Vazquez-Claverie, M., Karachi, C., et al. (2009). Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication. J. Neurochem. 110, 1321–1329. doi: 10.1111/j.1471-4159.2009.06220.x
Roseberry, T. K., Lee, A. M., Lalive, A. L., Wilbrecht, L., Bonci, A., and Kreitzer, A. C. (2016). Cell-type-specific control of brainstem locomotor circuits by basal ganglia. Cell 164, 526–537. doi: 10.1016/j.cell.2015.12.037
Rowe, J., Khan, A., Romanowski, C., Isaac, C., Khan, S., Mair, R., et al. (2016). Clinical experience with pedunculopontine nucleus stimulation in conditions with nigrostriatal disconnection. World Neurosurg. 89, 9–18. doi: 10.1016/j.wneu.2015.11.054
Ryczko, D., Auclair, F., Cabelguen, J. M., and Dubuc, R. (2016b). The mesencephalic locomotor region sends a bilateral glutamatergic drive to hindbrain reticulospinal neurons in a tetrapod. J. Comp. Neurol. 524, 1361–1383. doi: 10.1002/cne.23911
Ryczko, D., Cone, J. J., Alpert, M. H., Goetz, L., Auclair, F., Dube, C., et al. (2016a). A descending dopamine pathway conserved from basal vertebrates to mammals. Proc. Natl. Acad. Sci. U.S.A. 113, E2440–E2449. doi: 10.1073/pnas.1600684113
Ryczko, D., and Dubuc, R. (2013). The multifunctional mesencephalic locomotor region. Curr. Pharm. Des. 19, 4448–4470. doi: 10.2174/1381612811319240011
Ryczko, D., Gratsch, S., Auclair, F., Dube, C., Bergeron, S., Alpert, M. H., et al. (2013). Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proc. Natl. Acad. Sci. U.S.A. 110, E3235–E3242. doi: 10.1073/pnas.1301125110
Saavedra, J. M., Kvetnansky, R., and Kopin, I. J. (1979). Adrenaline, noradrenaline and dopamine levels in specific brain stem areas of acutely immobilized rats. Brain Res. 160, 271–280. doi: 10.1016/0006-8993(79)90424-4
Sano, I., Gamo, T., Kakimoto, Y., Taniguchi, K., Takesada, M., and Nishinuma, K. (1959). Distribution of catechol compounds in human brain. Biochim. Biophys. Acta 32, 586–587. doi: 10.1016/0006-3002(59)90652-3
Scarnati, E., Campana, E., and Pacitti, C. (1984). Pedunculopontine-evoked excitation of substantia nigra neurons in the rat. Brain Res. 304, 351–361. doi: 10.1016/0006-8993(84)90339-1
Scarnati, E., Proia, A., Di Loreto, S., and Pacitti, C. (1987). The reciprocal electrophysiological influence between the nucleus tegmenti pedunculopontinus and the substantia nigra in normal and decorticated rats. Brain Res. 423, 116–124. doi: 10.1016/0006-8993(87)90831-6
Schrader, C., Seehaus, F., Capelle, H. H., Windhagen, A., Windhagen, H., and Krauss, J. K. (2013). Effects of pedunculopontine area and pallidal DBS on gait ignition in Parkinson's disease. Brain Stimul. 6, 856–859. doi: 10.1016/j.brs.2013.05.005
Seidel, K., Mahlke, J., Siswanto, S., Kruger, R., Heinsen, H., Auburger, G., et al. (2015). The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Brain Pathol. 25, 121–135. doi: 10.1111/bpa.12168
Semba, K., and Fibiger, H. C. (1992). Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol. 323, 387–410. doi: 10.1002/cne.903230307
Shik, M. L., Severin, F. V., and Orlovskii, G. N. (1966). [Control of walking and running by means of electric stimulation of the midbrain]. Biofizika 11, 659–666.
Shine, J. M., Matar, E., Ward, P. B., Bolitho, S. J., Gilat, M., Pearson, M., et al. (2013). Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 136, 1204–1215. doi: 10.1093/brain/awt049
Sholomenko, G. N., Funk, G. D., and Steeves, J. D. (1991). Avian locomotion activated by brainstem infusion of neurotransmitter agonists and antagonists. II. gamma-Aminobutyric acid. Exp. Brain Res. 85, 674–681. doi: 10.1007/BF00231753
Sirota, M. G., Di Prisco, G. V., and Dubuc, R. (2000). Stimulation of the mesencephalic locomotor region elicits controlled swimming in semi-intact lampreys. Eur. J. Neurosci. 12, 4081–4092. doi: 10.1046/j.1460-9568.2000.00301.x
Smeets, W. J., Marin, O., and Gonzalez, A. (2000). Evolution of the basal ganglia: new perspectives through a comparative approach. J. Anat. 196(Pt 4), 501–517. doi: 10.1046/j.1469-7580.2000.19640501.x
Smetana, R., Juvin, L., Dubuc, R., and Alford, S. (2010). A parallel cholinergic brainstem pathway for enhancing locomotor drive. Nat. Neurosci. 13, 731–738. doi: 10.1038/nn.2548
Snijders, A. H., Leunissen, I., Bakker, M., Overeem, S., Helmich, R. C., Bloem, B. R., et al. (2011). Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 134, 59–72. doi: 10.1093/brain/awq324
Snijders, A. H., Takakusaki, K., Debu, B., Lozano, A. M., Krishna, V., Fasano, A., et al. (2016). Physiology of freezing of gait. Ann. Neurol. 80, 644–659. doi: 10.1002/ana.24778
Sourkes, T. L., and Poirier, L. (1965). Influence of the substantia nigra on the concentration of 5-hydroxytryptamine and dopamine of the striatum. Nature 207, 202–203. doi: 10.1038/207202a0
Stack, E., and Ashburn, A. (2008). Dysfunctional turning in Parkinson's disease. Disabil. Rehabil. 30, 1222–1229. doi: 10.1080/09638280701829938
Steeves, J. D., and Jordan, L. M. (1980). Localization of a descending pathway in the spinal cord which is necessary for controlled treadmill locomotion. Neurosci. Lett. 20, 283–288. doi: 10.1016/0304-3940(80)90161-5
Stefani, A., Peppe, A., Galati, S., Bassi, M. S., D'Angelo, V., and Pierantozzi, M. (2013). The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front. Neurol. 4:68. doi: 10.3389/fneur.2013.00068
Steiniger, B., and Kretschmer, B. D. (2003). Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus. Exp. Brain Res. 149, 422–430. doi: 10.1007/s00221-003-1382-z
Steininger, T. L., Rye, D. B., and Wainer, B. H. (1992). Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol. 321, 515–543. doi: 10.1002/cne.903210403
Tard, C., Delval, A., Devos, D., Lopes, R., Lenfant, P., Dujardin, K., et al. (2015). Brain metabolic abnormalities during gait with freezing in Parkinson's disease. Neuroscience 307, 281–301. doi: 10.1016/j.neuroscience.2015.08.063
Tattersall, T. L., Stratton, P. G., Coyne, T. J., Cook, R., Silberstein, P., Silburn, P. A., et al. (2014). Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat. Neurosci. 17, 449–454. doi: 10.1038/nn.3642
Thevathasan, W., Pogosyan, A., Hyam, J. A., Jenkinson, N., Foltynie, T., Limousin, P., et al. (2012). Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism. Brain 135, 148–160. doi: 10.1093/brain/awr315
Vercruysse, S., Leunissen, I., Vervoort, G., Vandenberghe, W., Swinnen, S., and Nieuwboer, A. (2015). Microstructural changes in white matter associated with freezing of gait in Parkinson's disease. Mov. Disord. 30, 567–576. doi: 10.1002/mds.26130
Versteeg, D. H., Van Der Gugten, J., De Jong, W., and Palkovits, M. (1976). Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res. 113, 563–574. doi: 10.1016/0006-8993(76)90057-3
Wang, M., Jiang, S., Yuan, Y., Zhang, L., Ding, J., Wang, J., et al. (2016). Alterations of functional and structural connectivity of freezing of gait in Parkinson's disease. J. Neurol. 263, 1583–1592. doi: 10.1007/s00415-016-8174-4
Weiss, P. H., Herzog, J., Potter-Nerger, M., Falk, D., Herzog, H., Deuschl, G., et al. (2015). Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers. Mov. Disord. 30, 1121–1125. doi: 10.1002/mds.26229
Welter, M. L., Demain, A., Ewenczyk, C., Czernecki, V., Lau, B., El Helou, A., et al. (2015). PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. J. Neurol. 262, 1515–1525. doi: 10.1007/s00415-015-7744-1
Windels, F., Thevathasan, W., Silburn, P., and Sah, P. (2015). Where and what is the PPN and what is its role in locomotion? Brain 138, 1133–1134. doi: 10.1093/brain/awv059
Wullimann, M. F. (2014). Ancestry of basal ganglia circuits: new evidence in teleosts. J. Comp. Neurol. 522, 2013–2018. doi: 10.1002/cne.23525
Xiao, C., Cho, J. R., Zhou, C., Treweek, J. B., Chan, K., McKinney, S. L., et al. (2016). Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways. Neuron 90, 333–347. doi: 10.1016/j.neuron.2016.03.028
Yamamoto, K., and Vernier, P. (2011). The evolution of dopamine systems in chordates. Front. Neuroanat. 5:21. doi: 10.3389/fnana.2011.00021
Yeo, S. S., Lee, D. G., Choi, B. Y., Chang, C. H., Jung, Y. J., Kim, S. H., et al. (2012). Neural connectivity of the pedunculopontine nucleus in relation to walking ability in chronic patients with intracerebral hemorrhage. Eur. Neurol. 67, 226–231. doi: 10.1159/000335248
Yoo, J. H., Zell, V., Wu, J., Punta, C., Ramajayam, N., Shen, X., et al. (2017). Activation of pedunculopontine glutamate neurons is reinforcing. J. Neurosci. 37, 38–46. doi: 10.1523/JNEUROSCI.3082-16.2017
Youn, J., Lee, J. M., Kwon, H., Kim, J. S., Son, T. O., and Cho, J. W. (2015). Alterations of mean diffusivity of pedunculopontine nucleus pathway in Parkinson's disease patients with freezing of gait. Parkinsonism Relat. Disord. 21, 12–17. doi: 10.1016/j.parkreldis.2014.10.003
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., and Price, D. L. (1989). The pedunculopontine nucleus in Parkinson's disease. Ann. Neurol. 26, 41–46. doi: 10.1002/ana.410260106
Keywords: locomotion, brainstem, dopamine, mesencephalic locomotor region, substantia nigra pars compacta, pedunculopontine nucleus, conservation, Parkinson's disease
Citation: Ryczko D and Dubuc R (2017) Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human. Front. Neurosci. 11:295. doi: 10.3389/fnins.2017.00295
Received: 08 March 2017; Accepted: 11 May 2017;
Published: 26 May 2017.
Edited by:
Brian R. Noga, University of Miami, United StatesReviewed by:
Abdel El Manira, Karolinska Institutet, SwedenPascal Darbon, University of Strasbourg, France
Copyright © 2017 Ryczko and Dubuc. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Réjean Dubuc, rejean.dubuc@gmail.com
†Present Address: Dimitri Ryczko, Département de Pharmacologie-Physiologie, Université de Sherbrooke, Sherbrooke, QC, Canada